<code id='A49DECD5CF'></code><style id='A49DECD5CF'></style>
    • <acronym id='A49DECD5CF'></acronym>
      <center id='A49DECD5CF'><center id='A49DECD5CF'><tfoot id='A49DECD5CF'></tfoot></center><abbr id='A49DECD5CF'><dir id='A49DECD5CF'><tfoot id='A49DECD5CF'></tfoot><noframes id='A49DECD5CF'>

    • <optgroup id='A49DECD5CF'><strike id='A49DECD5CF'><sup id='A49DECD5CF'></sup></strike><code id='A49DECD5CF'></code></optgroup>
        1. <b id='A49DECD5CF'><label id='A49DECD5CF'><select id='A49DECD5CF'><dt id='A49DECD5CF'><span id='A49DECD5CF'></span></dt></select></label></b><u id='A49DECD5CF'></u>
          <i id='A49DECD5CF'><strike id='A49DECD5CF'><tt id='A49DECD5CF'><pre id='A49DECD5CF'></pre></tt></strike></i>

          focus

          focus

          author:knowledge    Page View:97961
          Illustration of a person talking with a huge speech bubble over his head. -- health tech coverage from STAT
          Mike Reddy for STAT

          The health care sector is a notorious laggard when it comes to technology. It was slow to use computers, digitize patient data, and share information electronically. While most of the world instantly interacts via Zoom and Slack, hospitals — even today — are still sending faxes.

          But something different is happening with generative AI.

          advertisement

          Health systems, drugmakers, and insurers are racing to build the technology into their operations, aligning themselves with corporate giants such as Microsoft, Google, and Nvidia, whose executives speak about each incremental advancement of AI as an earth-shattering event. “The generative AI revolution is here,” Jensen Huang, 61, Nvidia’s leather-jacket-clad CEO, declared during the company’s GTC conference in San Jose, Calif., last week.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs
          Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

          LongtimeBluebirdBioCEONickLeschlyWendyMaeda/TheBostonGlobeSometwoyearsaftersplittingbiotechcompanyBl

          read more
          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more

          Laying a path for careers in science

          HighschoolstudentsconductedanexperimentattheBiogenCommunityLabinCambridge.Morethan25,000haveparticip